Our Promise
The Kos Foundation is dedicated to finding the best possible medication for four most common cancers:
- Brain Tumour,
- Brest Cancer,
- Colon/Rectum Cancer and
- Lung/Bronchus Cancer
through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with the cancer.
The Kos Foundation (TKF) exist for one reason and one reason only:
To accelerate the next generation of cancer's disease (CD) treatments.
In practice, that means identifying and funding projects most vital to patients. Spearheading solutions around seemingly intractable field-wide challenges; coordinating and streamlining the efforts of multiple, often disparate, teams; and doing whatever it takes to drive faster knowledge turns for the benefit of every life touched by CD. In principle, it means leveraging our core values of optimism, urgency, resourcefulness, collaboration, accountability and persistence in problem-solving to work on behalf of millions’ people worldwide living with cancer.
Do not forget worldwide there will be 25+ million new cases of cancer each year by 2040 having in mind that UK incidence is ranked higher than ⅔ of Europe and that the UK incidence ranked higher than 90% of the world.
Patients First
Our team works tirelessly every day with one urgent goal in mind to speed the breakthroughs that patients and their families can feel in their everyday lives.
We are Risk-Takers
We are one of the very rare founders who take risks in order to push the most promising treatments forward, and our approach in 11 years has transformed the CD research field completely.
Our Model is Different
We are tackling the overall challenge of getting better treatments to waiting patients by serving as a critical catalyst in both the patient and the research communities.
We even don't mind going out of business for patients!
We work to steward donations wisely and keep a tight rein on expenses.
We are proud of our track record of efficiency, with basically 100% of every pound spent since inception going straight to our programs.
We deliberately hold no endowment reserves however we do have excessive financial reserves. We act with extreme urgency, typically deploying funds raised even the same month in not the latest at the end of second month for the fastest possible impact.
We work to steward donations wisely and keep a tight rein on expenses.
We are proud of our track record of efficiency, with basically 100% of every pound spent since inception going straight to our programs.
Focus and determination is everything we do. We won't stop until the best possible medications for CD are found. We're on it.
We have only one definition of success: Scientific solutions that produce tangible improvements in patients' and their families lives.
